These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 369783)

  • 1. The recovery period following exposure of bacteria to penicillins.
    Wilson DA; Rolinson GN
    Chemotherapy; 1979; 25(1):14-22. PubMed ID: 369783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of R-factor-mediated beta-lactamase by Proteus mirabilis.
    Hesslewood SR; Smith JT
    Antonie Van Leeuwenhoek; 1974; 40(2):193-207. PubMed ID: 4599855
    [No Abstract]   [Full Text] [Related]  

  • 3. A microcalorimetric study on the action of penicillins on Staphylococcus aureus and Escherichia coli.
    Mårdh PA; Arhammer M; Andersson KE
    Chemotherapy; 1979; 25(2):106-16. PubMed ID: 36262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between the structure and function of polysynthetic penicillins].
    Naĭler Dzh
    Antibiotiki; 1971 Oct; 16(10):877-82. PubMed ID: 5003055
    [No Abstract]   [Full Text] [Related]  

  • 5. [Ampicillin and combination penicillins in clinical medicine (antibacterial effects)].
    Metz H
    Munch Med Wochenschr; 1972 Sep; 114(35):1515-9. PubMed ID: 4628080
    [No Abstract]   [Full Text] [Related]  

  • 6. [Drug sensitivity of bacteria isolated from clinical samples (author's transl)].
    Sawatari K; Mochida C; Iori F; Hayashi A; Nasu M
    Jpn J Antibiot; 1980 Jan; 33(1):87-96. PubMed ID: 6990050
    [No Abstract]   [Full Text] [Related]  

  • 7. [Antimicrobial activities of sulbactam/ampicillin against clinically isolated microbial strains].
    Deguchi K; Yokota N; Koguchi M; Suzuki Y; Fukayama S; Ishihara R; Oda S; Tanaka S; Nakane Y; Fukumoto T
    Jpn J Antibiot; 1995 Apr; 48(4):529-47. PubMed ID: 7783316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The response of Staphylococcus aureus to benzylpenicillin.
    Elliott TS; Greenwood D; Rodgers FG; O'Grady F
    Br J Exp Pathol; 1979 Feb; 60(1):14-23. PubMed ID: 256748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of saliva and alpha-amylase on antibiotic sensitivity of bacteria.
    Eke PI; Rotimi VO; Odugbemi TO; Dosunmu-Ogunbi OO
    Afr J Med Med Sci; 1984; 13(1-2):15-20. PubMed ID: 6087634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Resistance to beta-lactam antibiotics Proteus strains.
    Lachmajer-Lutoslawska M; Bobrowski M
    Acta Microbiol Pol A; 1975; 8(3):141-9. PubMed ID: 1103580
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An extracellular penicillinase controlled by an R factor].
    Romero E; Perduca M
    G Batteriol Virol Immunol Microbiol; 1973; 66(7-12):204-10. PubMed ID: 4605499
    [No Abstract]   [Full Text] [Related]  

  • 12. Epidemiology of beta-lactamases in Africa: correlation with resistance to beta-lactam antibiotics.
    Dowse LJ; Prigent BM
    Clin Ther; 1991; 13(2):243-53. PubMed ID: 1863940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibacterial activity of the combination trimethoprim-sulfamethoxazole compared with antibiotics].
    Böhni E
    Schweiz Med Wochenschr; 1969 Oct; 99(42):1505-10. PubMed ID: 4903288
    [No Abstract]   [Full Text] [Related]  

  • 14. [Antibacterial activity of aminocyclohexylpenicillin(AC-PC)].
    Tsuchiya K; Oishi T; Iwagishi C
    Jpn J Antibiot; 1970 Feb; 23(1):30-6. PubMed ID: 4393603
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacodynamic effects of sub-MICs of benzylpenicillin against Streptococcus pyogenes in a newly developed in vitro kinetic model.
    Löwdin E; Odenholt I; Bengtsson S; Cars O
    Antimicrob Agents Chemother; 1996 Nov; 40(11):2478-82. PubMed ID: 8913449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Bactericidal activity of serum and chemotherapy in sensitive and resistant exciter (author's transl)].
    Eyer H; Metz H; Preac-Mursic V
    Med Klin; 1975 Nov; 70(47):1915-9. PubMed ID: 765704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Resistance of clinical strains of Proteus to various beta-lactam antibiotics].
    Shvidenko IG
    Antibiotiki; 1976 Oct; 21(10):910-4. PubMed ID: 793508
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of mecillinam and 6-aminopenicillanic acid on Proteus mirabilis, Escherichia coli, and Staphylococcus aureus.
    Lorian V; Atkinson B
    Antimicrob Agents Chemother; 1977 Mar; 11(3):541-52. PubMed ID: 193439
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Distribution and changes in the susceptibility of bacteria isolated from clinical samples. II].
    Deguchi K; Fukayama S; Nishimura Y; Nishike A; Oda S; Sato S; Matsumoto Y; Ikegami R; Yokota N; Tanaka S
    Jpn J Antibiot; 1985 Jun; 38(6):1587-602. PubMed ID: 3900459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparative in vitro activity of amoxicillin and ampicillin against bacteria isolated from ill children.
    Marks MI
    Curr Ther Res Clin Exp; 1974 Oct; 16(10):1137-44. PubMed ID: 4154827
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.